Erytra blood group analyser and kode technology testing of SARS‐CoV‐2 antibodies among convalescent patients and vaccinated individuals-Reference-Cited by-同舟云学术

Erytra blood group analyser and kode technology testing of SARS‐CoV‐2 antibodies among convalescent patients and vaccinated individuals

Published:2021-11-26 Issue:1 Volume:3 Page:72-79
ISSN:2688-6146
Container-title:eJHaem
language:en
Short-container-title:eJHaem

Author:

Weinstock Christof¹^ORCID,Flegel Willy A.²^ORCID,Srivastava Kshitij²,Kaiser Sabine¹,Schrezenmeier Hubert¹,Tsamadou Chrysanthi¹,Ludwig Carolin¹,Jahrsdörfer Bernd¹,Bovin Nicolai V.³,Henry Stephen M.³^ORCID

Affiliation:

1. Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Service Baden‐Württemberg – Hessen; Department of Transfusion Medicine Ulm University Ulm Germany

2. Department of Transfusion Medicine NIH Clinical Center, National Institutes of Health Bethesda Maryland USA

3. Centre for Kode Technology Innovation School of Engineering Computer and Mathematical Sciences, Faculty of Design and Creative Technologies Auckland Stephen Henry Auckland New Zealand

Funder

NIH Clinical Center

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jha2.352

Reference15 articles.

1. Independent Side-by-Side Validation and Comparison of 4 Serological Platforms for SARS-CoV-2 Antibody Testing

2. COVID ‐19 antibody screening with SARS‐CoV ‐2 red cell kodecytes using routine serologic diagnostic platforms

3. COVID-19 Antibody Detection and Assay Performance Using Red Cell Agglutination

4. Transmission of MERS-Coronavirus in Household Contacts

5. SachsMC.Generate ROC curve charts for print and interactive use. Available from:https://cran.r‐project.org/web/packages/plotROC/vignettes/examples.html. Accessed 29 Oct 2021.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The highest Duffy (FYX) allele frequency ever reported for Scottish population: A cross‐sectional study;Health Science Reports;2023-06

2. Modified Hemagglutination Tests for COVID-19 Serology in Resource-Poor Settings: Ready for Prime-Time?;Vaccines;2022-03-08